Human Study on Collaborative Pharmacy Practice Agreements (CPPAs)
This observational study assessed the implementation of CPPAs in specialty clinics and found that they improved patient care by shortening time to treatment and enhancing monitoring. The study noted high compatibility with clinic workflows and strong acceptance among clinic staff, along with a need for resources to support the implementation. Pharmacists ordered 2,388 medications and 764 laboratory tests after CPPA implementation.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Limited
- Outcome
- Not reported
Why it matters
The findings suggest that CPPAs can be beneficial in enhancing patient care within integrated health systems, promoting more efficient workflows and better outcomes for patients. However, it's important to note that the study did not measure direct clinical outcomes.
What this does not prove
The study focused on the implementation and perceptions of CPPAs without assessing actual clinical outcomes, limiting the ability to conclude their effectiveness directly.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Observational
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-27
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceAssessment of development and implementation of collaborative practice agreements in an integrated health system specialty pharmacy. ↗DOI: 10.1093/ajhp/zxag363
Supporting passages (7)
study designMETHODS: An observational, cross-sectional, mixed-methods convergent study design was used to assess CPPA implementation in infectious diseases (ID), multiple sclerosis and neuroimmunology (MSN), hemostasis, hepatology, neurology-movement disorders, and cystic fibrosis (CF) clinics.
publication datePublication date: 2026-10-27
interventionPURPOSE: The purpose of this study was to describe the development and implementation of collaborative pharmacy practice agreements (CPPAs) in an integrated health-system specialty pharmacy (HSSP) using the RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework.
findingsPost-CPPA implementation themes highlighted improved patient care, including shorter time to treatment and better monitoring; high compatibility with existing clinic workflow; high acceptability by clinic staff; and the need for resources to support implementation.
limitationsTitle: Assessment of development and implementation of collaborative practice agreements in an integrated health system specialty pharmacy.
peer reviewedPublication types: Journal Article
subjectsPost-CPPA implementation themes highlighted improved patient care, including shorter time to treatment and better monitoring; high compatibility with existing clinic workflow; high acceptability by clinic staff; and the need for resources to support implementation.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.